These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20383650)

  • 21. [What do large clinical trials learn us about cardiovascular and renal prevention in patients with type 2 diabetes mellitus and hypertension?].
    Dussol B; Berland Y
    Nephrol Ther; 2006 May; 2(2):51-74. PubMed ID: 16895717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Socio-economic inequalities in the prevalence of Type 2 diabetes, cardiovascular risk factors and chronic diabetic complications in the Basque Country, Spain.
    Larrañaga I; Arteagoitia JM; Rodriguez JL; Gonzalez F; Esnaola S; Piniés JA;
    Diabet Med; 2005 Aug; 22(8):1047-53. PubMed ID: 16026371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type 2 diabetes mellitus: a high-risk condition for cardiovascular disease irrespective of the different degrees of obesity.
    Song SH; Hardisty CA
    QJM; 2008 Nov; 101(11):875-9. PubMed ID: 18776208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type 2 diabetes mellitus: prevention of macrovascular complications.
    Meeuwisse-Pasterkamp SH; van der Klauw MM; Wolffenbuttel BH
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):323-41. PubMed ID: 18327994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of cardiovascular risk factors in type 2 diabetic patients undergoing coronary angiography.
    Wang L; Li J; Song S; Yao R; Feng G
    Croat Med J; 2003 Dec; 44(6):712-5. PubMed ID: 14652884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2.
    de Luis DA; Fernandez N; Arranz ML; Aller R; Izaola O; Romero E
    J Diabetes Complications; 2005; 19(1):42-6. PubMed ID: 15642489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in chronic complications of type 2 diabetic patients from Spanish primary health care centres (GEDAPS study): ten year-implementation of St. Vincent recommendations.
    Mundet X; Cano F; Mata-Cases M; Roura P; Franch J; Birules M; Gimbert R; Llusa J; Cos X
    Prim Care Diabetes; 2012 Apr; 6(1):11-8. PubMed ID: 21757413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Macrovascular complications and their associated risk factors in type 2 diabetic patients in Sana'a city, Yemen.
    Al-Khawlani A; Atef ZA; Al-Ansi A
    East Mediterr Health J; 2010 Aug; 16(8):851-8. PubMed ID: 21469567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factor analyses for macrovascular complication in nonobese NIDDM patients. Multiclinical Study for Diabetic Macroangiopathy (MSDM).
    Ito H; Harano Y; Suzuki M; Hattori Y; Takeuchi M; Inada H; Inoue J; Kawamori R; Murase T; Ouchi Y; Umeda F; Nawata H; Orimo H
    Diabetes; 1996 Jul; 45 Suppl 3():S19-23. PubMed ID: 8674883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Depressive symptoms, serious psychological distress, diabetes distress and cardiovascular risk factor control in patients with type 2 diabetes.
    Winchester RJ; Williams JS; Wolfman TE; Egede LE
    J Diabetes Complications; 2016 Mar; 30(2):312-7. PubMed ID: 26657725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel determinants preventing achievement of major cardiovascular targets in type 2 diabetes.
    Camara S; Bouenizabila E; Hermans MP; Ahn SA; Rousseau MF
    Diabetes Metab Syndr; 2014; 8(3):145-51. PubMed ID: 25220917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological primary and secondary cardiovascular prevention among diabetic patients in a multiethnic general practice population: still room for improvements.
    Tran AT; Straand J; Dalen I; Birkeland KI; Claudi T; Cooper JG; Meyer HE; Jenum AK
    BMC Health Serv Res; 2013 May; 13():182. PubMed ID: 23688317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of lifestyle intervention in patients with type 2 diabetes: a meta-analysis.
    Chen L; Pei JH; Kuang J; Chen HM; Chen Z; Li ZW; Yang HZ
    Metabolism; 2015 Feb; 64(2):338-47. PubMed ID: 25467842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in vascular risk factors and medication use in patients with various manifestations of vascular diseases or type 2 diabetes mellitus from 1996 to 2007: the Second Manifestations of ARTerial disease study.
    Vlek A; Visseren F; Algra A; Soedamah-Muthu S; Moll F; Doevendans P; Kappelle J; van der Graaf Y;
    Eur J Cardiovasc Prev Rehabil; 2010 Dec; 17(6):628-36. PubMed ID: 20300000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Risk profile and macroangiopathy in type II diabetics in medical practice].
    Stiegler H; Standl E; Standl R; Rebell B; Ziegler A; Janka HU; Schulz K; Roth R; Lehmacher W
    Vasa; 1990; 19(2):119-28. PubMed ID: 2371785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The Tanno and Sobetsu study].
    Ohnishi H; Saitoh S; Shimamoto K
    Nihon Rinsho; 2010 May; 68(5):839-42. PubMed ID: 20446579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A long-term quality-of-care score for predicting the occurrence of macrovascular diseases in patients with type 2 diabetes mellitus.
    Li PI; Wang JN; Guo HR
    Diabetes Res Clin Pract; 2018 May; 139():72-80. PubMed ID: 29481816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trialogue Plus: Management of cardiovascular risk in hyperglycaemic/diabetic patients at hospital discharge.
    Beltramello G; Manicardi V; Mazzuoli F; Rivellese A;
    Acta Diabetol; 2013 Dec; 50(6):989-98. PubMed ID: 24121870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapy and clinical trials: fibrate therapy in type 2 diabetes - where are we now?
    Peter R; Reilly E; Anthony S
    Curr Opin Lipidol; 2010 Dec; 21(6):554-5. PubMed ID: 21206346
    [No Abstract]   [Full Text] [Related]  

  • 40. Failure to control risk factors among patients with type 2 diabetes; experience from a Greek cohort.
    Kollias A; Bliziotis IA; Xilomenos A; Tolis A
    Prim Care Diabetes; 2009 Nov; 3(4):249-52. PubMed ID: 19720571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.